Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors

Prostate

Volumn 29, Issue 1, 1996, Pages 36-41

  Krekels, Marita D W G ^a   Zimmerman, Jacco ^a   Janssens, Boudewijn ^a   Van Ginckel, Robert ^a   Cools, Willy ^a   Van Hove, Carl ^a   Coene, Marie Claire ^a   Wouters, Walter ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

inhibition; liarozole fumarate; oxidative metabolism; rat Dunning R3327G tumors; rat liver; retinoic acid

Indexed keywords

LIAROZOLE FUMARATE; RETINOIC ACID; TRITIUM;

AEROBIC METABOLISM; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CATABOLISM; CONTROLLED STUDY; ENZYME KINETICS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; FEMALE; IMIDAZOLES; KINETICS; LIVER; MALE; NADP; OXIDATION-REDUCTION; PROSTATIC NEOPLASMS; RATS; RATS, WISTAR; TRETINOIN;

EID: 0029942117     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199607)29:1<36::AID-PROS5>3.0.CO;2-G     Document Type: Article

References (27)

1. Mahler G, Verhelst J, Denis L: Ketoconazole and liarozole in the treatment of advanced prostatic cancer. Cancer 71(Suppl):1068-1073, 1993.
2. Dijkman GA, Van Moorselaar RJA, Van Ginckel R, Van Stratum P, Wouters L, Debruyne FMJ, Schalken JA, De Coster R: Antitumoral effects of liarozole in androgen-dependent and -independent R3327-Dunning prostate adenocarcinomas. J Urol 151:217-222, 1994.
3. Smets G, Van Ginckel R, Daneels G, Moeremans M, Van Wauwe J, Coene M-C, Ramaekers FCS, Schalken JA, Borgers M, De Coster R: Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6 sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid. Prostate, 27:129-140, 1995.
4. Jones-Villeneuve EMV, McBurney MW, Rogers KA, Kalnins VI: Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol 94:253-262, 1982.
5. Strickland S, Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393-403, 1978.
6. Matsushima Y, Kawachi E, Tanaka H, Kagechika H, Hashimoto Y, Shudo K: Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells. Biochem Biophys Res Commun 2:1136-1142, 1992.
7. Parkinson DR, Smith MA, Cheson BD, Stevenson HC, Friedmans MA: Trans-retinoic acid and related differentiation agents. Semin Oncol 19:734-741, 1992.
8. Favennec L, Cals MJ: The biological effects of retinoids on cell differentiation and proliferation. J Clin Chem Biochem 26:479-489, 1988.
9. Lotan R: Mechanisms of action of retinoids. Cancer Bull 38:113-116, 1986.
10. Napoli JL, McCormick AN: Tissue dependence of retinoic acid metabolism in vivo. Biochim Biophys Acta 666:165-175, 1981.
11. Swanson BN, Frolik CA, Zakarevitz DW, Roller PP, Sporn MB: Dose-dependent kinetics of all-trans-retinoic acid in rats. Biochem Pharmacol 30:107-113, 1979.
12. Frolik CA, Roberts AB, Tavela TE, Roller PP, Newton DL, Sporn MB: Isolation and identification of 4-hydroxy- and 4-oxo-retinoic acid. In vitro metabolites of all-trans-retinoic acid in hamster trachea and liver. Biochemistry 18:2092-2097, 1979.
13. Roberts AB, Lamb LC, Sporn MB: Metabolism of all-trans-retinoic acid in hamster liver microsomes. Oxidation of 4-hydroxy- to 4-keto-retinoic acid. Arch Biochem Biophys 199:374-383, 1980.
14. Frolik CA, Roller PP, Roberts AB, Sporn MB: In vitro and in vivo metabolism of all-trans- and 13-cis-retinoic acid in hamsters. J Biol Chem 255:8057-8062, 1980.
15. Leo MA, Iida S, Lieber CS: Retinoic acid metabolism by a system reconstituted with cytochrome P450. Arch Biochem Biophys 234:305-312, 1984.
16. Varani J, Gendimenico GA, Shah B, Gibbs D, Capetola RJ, Mezick JA, Voorhees JJ: A direct comparison of pharmacologic effects of retinoids on skin cells in vitro and in vivo. Skin Pharmacol 4:254-261, 1991.
17. Vanden Bossche H, Willemsens G: Retinoic acid and cytochrome P450. In Saurat JH (ed): "Retinoids: 10 Years On." Basel: Karger, 1990, pp 79-88.
18. Bhat PV, Lacroix A: Metabolism of retinol and retinoic acid in N-methyl-N-nitrosourea-induced mammary carcinomas in rats. Cancer Res 49:139-144, 1989.
19. Williams JB, Napoli JL: Metabolism of retinoic acid and retinol during differentiation of F9 and embryonal carcinoma cells. Proc Natl Acad Sci USA 82:4658-4662, 1985.
20. Napoli JL: Retinol metabolism in LCC-PK1 cells. J Biol Chem 261:13592-13597, 1986.
21. Van Wauwe JP, Coene M-C, Goossens J, Monbaliu J: Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats. J Pharmacol Exp Ther 252:365-369, 1990.
22. Van Wauwe J, Van Nyen G, Coene M-C, Stoppie P, Cools W, Goossens J, Borghgraef P, Janssen PAJ: Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J Pharmacol Exp Ther 261:773-779, 1992.
23. Wouters W, van Dun J, Dillen A, Coene M-C, Cools W, De Coster R: Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 breast cancer cells. Cancer Res 52:2841-2846, 1992.
24. 3H]-retinoic acid in cell cultures. J Pharmacol Tox Methods, in press.
25. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
26. Van Wauwe JP, Coene M-C, Goossens J, Van Nijen G, Cools W, Lauwers W: Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid. J Pharmacol Exp Ther 245:718-722, 1988.
27. Van Wauwe JP, Coene M-C, Cools W, Goossens J, Lauwers W, Le Jeune L, Van Hove C, Van Nyen G: Liarozole fumarate inhibits the metabolism of 4-keto-all-trans-retinoic acid. Biochem Pharmacol 47:737-741, 1994.